Rosuvastatin-induced thrombocytopenia

Southern Medical Journal

Volumn 103, Issue 7, 2010, Pages 676-678

  Vrettos, Ioannis ^a   Papageorgiou, Sotiris ^a   Economopoulou, Christina ^a   Pappa, Vasiliki ^a   Tsirigotis, Panagiotis ^a   Tountas, Nikolaos ^a   Economopoulos, Theofanis ^a   Dervenoulas, John ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Drug induced thrombocytopenia; rosuvastatin; statins

Indexed keywords

C REACTIVE PROTEIN; ELECTROLYTE; HEMOGLOBIN; ROSUVASTATIN; TUMOR MARKER;

AGED; ANAMNESIS; APPENDECTOMY; ARTICLE; ASPIRATION; BLOOD CELL COUNT; BLOOD SMEAR; BONE MARROW BIOPSY; CASE REPORT; CELL STRUCTURE; DRUG WITHDRAWAL; DYSLIPIDEMIA; ECHOGRAPHY; EOSINOPHIL; ERYTHROCYTE SEDIMENTATION RATE; ERYTHROPOIESIS; FEMALE; HUMAN; KIDNEY FUNCTION TEST; LEUKOCYTE COUNT; LIVER FUNCTION TEST; LYMPHOCYTE; MEGAKARYOCYTE; MONOCYTE; MYELOPOIESIS; NEUTROPHIL; PHYSICAL EXAMINATION; THORAX RADIOGRAPHY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THYROID FUNCTION TEST; TREATMENT DURATION; VITILIGO;

AGED; DYSLIPIDEMIAS; FEMALE; FLUOROBENZENES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PYRIMIDINES; SULFONAMIDES; THROMBOCYTOPENIA;

EID: 77954241912     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e3181e170f5     Document Type: Article

References (15)

1. Cheng JW. Rosuvastatin in the management of hyperlipidemia. Clin Ther 2004;26:1368-1387.
2. Davignon J, Montigny M, Dufour R. HMG-CoA reductase inhibitors: a look back and a look ahead. Can J Cardiol 1992;8:843-864.
3. Vaughan CJ, Murphy MB, Buckley BM. Statins do more than just lower cholesterol. Lancet 1996;348:1079-1082.
4. Shepherd J, Vidt DG, Miller E, et al. Safety of rosuvastatin: update on 16,876 rosuvastatin-treated patients in a multinational clinical trial program cardiology. Cardiology 2007;107:433-443.
5. Knopp RH. Drug treatment of lipid disorders. N Engl J Med 1999;341: 498-511.
6. González-Ponte ML, González-Ruiz M, Duvós E, et al. Atorvastatininduced severe thrombocytopenia. Lancet 1998;352:1284.
7. Groneberg DA, Barkhuizen A, Jeha T. Simvastatin-induced thrombocytopenia. Am J Hematol 2001;67:277.
8. Yamada T, Shinohara K, Katsuki K. Severe thrombocytopenia caused by simvastatin in which thrombocyte recovery was initiated after severe bacterial infection. Clin Drug Investig 1998;16:172-174.
9. Possamai G, Bovo P, Santonastaso M. Thrombocytopenic purpura during therapy with simvastatin. Haematologica 1992;77:357-358.
10. Ames PR. Simvastatin-induced thrombocytopaenia: a further case and a brief on its clinical relevance. Ann Hematol 2008;87:773-774.
11. Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. N Engl J Med 2007;357:580-587.
12. Kenney B, Stack G. Drug-induced thrombocytopenia. Arch Pathol Lab Med 2009;133:309-314.
13. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996;88:3-40.
14. George JN, Raskob GE, Shah SR, et al. Drug-induced thrombocytopenia: a systematic review of published case reports. Ann Intern Med 1998;129:886-890.
15. Nikolsky E, Sadeghi HM, Effron MB, et al. Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarction. Am J Cardiol 2005;96:474-481.